Adrenal carcinoma is a rare cancer that starts in the outer layer of the adrenal gland. It can cause hormone changes that lead to weight gain, high blood pressure, facial fullness, or muscle weakness. Many people first hear about adrenal carcinoma when unexplained hormone-related symptoms continue despite routine care. It often grows over months to years and may spread, but outcomes vary by stage and treatment. Care usually includes surgery when possible, with medicines, radiation, or chemotherapy to control remaining cancer and hormone effects.
Overview
Adrenal carcinomaSymptoms
Adrenal carcinoma symptoms vary. Early symptoms of adrenal carcinoma may include belly or back pain, fullness, unexplained weight changes, and fatigue. Many also notice hormone effects—easy bruising, high blood pressure, muscle weakness, or changes in body hair, periods, or sexual function.
Outlook and prognosis
Many living with adrenal carcinoma face an aggressive cancer, but outcomes vary widely with stage, tumor size, and how completely it’s removed. Early diagnosis and expert surgery offer the best chance for long-term control. Ongoing follow-up helps manage hormone effects and spot recurrences.
Causes and risk factors
Adrenal carcinoma’s exact cause is unclear. Risk rises with certain inherited syndromes (Li-Fraumeni, Lynch, Beckwith‑Wiedemann, sometimes MEN1), younger childhood or mid‑adult age, and female sex. Environmental and lifestyle links are limited; prior radiation exposure or long‑term carcinogens remain uncertain contributors.
Genetic influences
Genetics plays a meaningful role in adrenal carcinoma, though most cases are sporadic. Inherited syndromes—such as Li-Fraumeni, Lynch, MEN1, and Beckwith‑Wiedemann—raise risk. Tumor genetics also guides prognosis and targeted therapies, so genetic counseling and testing are often recommended.
Diagnosis
Doctors suspect adrenal carcinoma from symptoms or hormone excess, then order blood and urine tests plus CT or MRI. Diagnosis of adrenal carcinoma is confirmed after surgery by examining the tumor under a microscope; biopsy is rarely done.
Treatment and drugs
Adrenal carcinoma care usually blends surgery to remove the tumor with medicines that target hormone excess and cancer growth. Many receive chemotherapy, newer targeted drugs, or immunotherapy, sometimes with radiation. Teams adjust treatment to tumor stage, hormone activity, and overall health.
Symptoms
Adrenal carcinoma often shows up through hormone-related changes in weight, blood pressure, body hair, or mood. Early symptoms of adrenal carcinoma can be subtle, sometimes mistaken for stress or normal aging. Symptoms vary from person to person and can change over time. As the tumor grows, some people also notice abdominal fullness, pain, or unexplained fatigue.
Weight gain around the belly and a fuller face can appear even if eating habits haven’t changed. Belts may feel tighter while arms and legs stay relatively thin. Too much cortisol from the adrenal gland is a common driver.
Thin, fragile skin can bruise easily, and purple stretch marks may show on the abdomen, hips, or thighs. Small cuts may heal more slowly. These changes are linked to high cortisol levels.
Climbing stairs or rising from a chair can feel harder than before. Carrying groceries or lifting objects may take extra effort. Cortisol excess can break down muscle over time.
New or worsening high blood pressure can be hard to control with usual medication. Headaches or a pounding heartbeat may show up, though many feel no symptoms. Hormone-producing adrenal carcinoma can raise blood pressure.
How people usually first notice Adrenal carcinoma?
People often first notice adrenal carcinoma when vague, everyday symptoms don’t add up: unexplained weight gain or loss, new high blood pressure that’s hard to control, muscle weakness, or changes like acne and excess facial or body hair. Some develop sudden abdominal or back pain, or see signs of hormone imbalance such as irregular periods, low libido, mood changes, or easy bruising; rarely, a firm mass in the upper abdomen is felt. For children, families may spot rapid growth, early puberty signs, or virilization (more adult-type hair growth and body changes), prompting a checkup that leads to the diagnosis.
Types of Adrenal carcinoma
Adrenal carcinoma can look different from one person to the next, and the main “types” doctors describe are based on how the tumor behaves and what hormones it makes. Some tumors pump out extra hormones and cause noticeable body changes; others stay “silent” until they grow large. Clinicians often describe them in these categories: functioning versus nonfunctioning tumors, stage or spread, and how the cells look under a microscope. Understanding the types of adrenal carcinoma can help make sense of early symptoms of adrenal carcinoma and guide testing and treatment.
Functioning tumors
These make extra hormones like cortisol, aldosterone, or androgens. People may notice weight gain in the face and trunk, new or worsening high blood pressure, irregular periods, or rapid hair growth and acne. Symptoms often show up earlier because the hormone changes are harder to miss.
Nonfunctioning tumors
These do not make excess hormones. Many feel well at first and only develop symptoms from the tumor’s size, such as belly fullness or back pain. They are often found during imaging done for another reason.
Local disease
The cancer is limited to the adrenal gland or nearby tissue. Symptoms are often driven by hormones if the tumor is functioning, or by pressure in the upper abdomen if it is not. Surgery is usually the main treatment at this stage.
Regional spread
Cancer cells have reached nearby lymph nodes or structures. People may have a mix of hormone-related symptoms and discomfort from local invasion, like persistent side or back pain. Fatigue and unintentional weight loss can appear as the body works harder to cope.
Distant metastasis
The cancer has spread to organs such as the liver, lungs, or bones. Symptoms can include bone pain, cough or shortness of breath, and more pronounced fatigue and weight loss. Hormone-related symptoms may continue if the tumor is functioning.
High-grade histology
Under the microscope, cells look very abnormal and divide quickly. These tumors tend to grow and spread faster, so symptoms may escalate over weeks to months. Treatment plans often include multiple therapies to control growth and hormones.
Low-grade histology
Cells look closer to normal and usually grow more slowly. Symptoms may progress over months to years, sometimes with milder hormone effects. Close monitoring and targeted treatment can help manage changes over time.
What genetics can tell you about symptoms
Some adrenal carcinomas arise from inherited changes in tumor‑suppressor genes, like TP53 (Li‑Fraumeni syndrome), which can lead to earlier onset, larger adrenal masses, and hormone overproduction. Excess cortisol may cause weight gain and bruising, while excess androgens can trigger acne and facial hair.
Causes and risk factors
Most adrenal carcinoma starts without a clear cause and is not inherited. Doctors distinguish between risk factors you can change and those you can’t. Inherited syndromes such as Li‑Fraumeni or Beckwith‑Wiedemann can raise the chance, and risk can be higher in some families. Risk is higher in childhood and again in mid‑life, and it is diagnosed more often in women than men. Few lifestyle or environmental links are proven for adrenal carcinoma, so risk factors for adrenal carcinoma focus mainly on genetics and age.
Environmental and biological risk factors
Adrenal carcinoma is rare, so understanding what raises or lowers your chances can be reassuring. Many people searching for early symptoms of adrenal carcinoma also want to know who is more likely to be affected. Doctors often group risks into internal (biological) and external (environmental). Below are well-established patterns and what research currently shows.
Adrenal carcinoma has two peaks—one in early childhood and another in mid-adulthood. These age patterns suggest internal development and hormone timing may influence risk. The exact reasons are still being studied.
Women are diagnosed with adrenal carcinoma more often than men. Differences in hormone biology may contribute to this pattern. The precise cause of the gap is not fully understood.
No specific chemical or pollutant has been consistently linked to adrenal carcinoma. Studies on pesticides, industrial chemicals, and air pollution remain inconclusive. More large, long-term studies are needed.
High-dose radiation to the abdomen increases general cancer risk, but a clear link to adrenal carcinoma has not been shown. If exposure happened in childhood, regular follow-up is often recommended for overall cancer screening. Current data do not confirm a direct connection to this tumor.
Genetic risk factors
Genetic changes play a central role in how adrenal carcinoma develops. Most cases arise from DNA changes that occur only in the tumor, while a smaller share come from inherited syndromes that raise lifetime risk, sometimes at younger ages. Carrying a genetic change doesn’t guarantee the condition will appear. If you’re exploring genetic risk factors for adrenal carcinoma, knowing whether changes are inherited or only in the tumor helps guide testing and family discussions.
Li-Fraumeni syndrome: An inherited change in the TP53 gene, which helps control cell growth, strongly raises the risk of adrenal carcinoma. The risk is highest in childhood but can extend into adulthood.
Beckwith-Wiedemann syndrome: Changes in chromosome 11 imprinting can boost a growth signal called IGF2, increasing childhood risk of adrenal carcinoma. People with this overgrowth syndrome have a higher chance of several childhood tumors.
Lynch syndrome: Inherited changes in DNA mismatch repair genes slightly increase the chance of adrenal carcinoma. This syndrome is better known for colon and uterine cancers, but the adrenal cortex can be affected.
MEN1 syndrome: Variants in the MEN1 gene raise the chance of adrenal tumors; most are benign, but adrenal carcinoma can occur. Risk varies within families.
Familial clustering: Rare families have multiple cases of adrenal carcinoma without a recognized syndrome. This points to inherited risk even when a specific gene is not found.
IGF2 overactivity: Many adrenal carcinoma tumors show high activity of the IGF2 gene, a powerful growth signal. This is usually a tumor-only change rather than something inherited.
TP53 tumor changes: Beyond inherited cases, many adrenal carcinoma tumors acquire TP53 damage within the cancer cells. This loss of a key growth brake can drive aggressive behavior.
WNT pathway changes: Alterations in genes that control the WNT pathway, such as CTNNB1 or loss of ZNRF3, are common in adrenal carcinoma. These changes push cells to grow and divide.
Telomere gene changes: Some tumors activate TERT or lose ATRX, which helps cancer cells keep dividing. These are tumor-acquired changes seen in a subset of adrenal carcinoma.
Chromosomal instability: Many adrenal carcinoma tumors carry large DNA losses and extra copies of chromosomes. This widespread genetic imbalance helps cancer cells grow and spread.
Lifestyle risk factors
Evidence directly linking lifestyle to Adrenal carcinoma is limited, but metabolism and hormone-related pathways affected by daily habits may influence risk or tumor behavior. Below is a pragmatic view of lifestyle risk factors for Adrenal carcinoma, drawing from endocrine and cancer biology. Where evidence is indirect or emerging, this is noted. People often ask about lifestyle risk factors for Adrenal carcinoma; current data are sparse but suggest several modifiable areas that may matter.
Adiposity alters insulin/IGF signaling and steroid metabolism, which can create growth signals for adrenal cortical cells. Limited observational data hint that higher BMI may be associated with adrenal tumors, though causation is unproven. Keeping weight in a healthy range may reduce these pro-growth hormonal cues.
Low activity worsens insulin resistance and systemic inflammation that can promote cell proliferation in hormone-producing tissues like the adrenal cortex. Regular movement improves insulin sensitivity and lowers inflammatory signaling that could support tumor growth. Even moderate exercise may help normalize steroid hormone dynamics.
Diets high in ultra-processed foods, refined carbs, and processed meats drive hyperinsulinemia and inflammation that may foster adrenal tumor biology. Fiber-rich, plant-forward patterns improve insulin and bile acid metabolism that intersect with steroid pathways. While direct ACC data are scarce, dietary choices that reduce anabolic signaling may be protective.
Tobacco exposure increases oxidative stress and can disrupt steroid hormone balance; some studies note more adrenal masses among smokers, though links to carcinoma are not definitive. Avoiding smoking removes a potential promoter of DNA damage and improves outcomes if surgery or therapy is needed. Smoking cessation is advisable given possible adrenal effects.
Risk prevention
There’s no guaranteed way to prevent adrenal carcinoma, but you can lower risk and catch problems earlier. This cancer is rare, so the biggest gains often come from identifying who is at higher risk and setting up a plan. Knowing your risks can guide which preventive steps matter most. For families with inherited syndromes, regular screening and prompt attention to new symptoms can make a real difference.
Ask relatives about cancers diagnosed at young ages or rare endocrine tumors. Share this history with your doctor so they can judge your adrenal carcinoma risk.
A genetics professional can review your personal and family history and discuss testing for inherited syndromes linked to adrenal carcinoma. Results can guide screening plans for you and, if needed, for relatives.
If you carry a relevant genetic change (like in Li-Fraumeni or Lynch syndromes), your team may suggest regular hormone blood/urine tests and periodic abdominal imaging. These checks aim to find adrenal carcinoma earlier, when treatment options are broader.
Learn the early symptoms of adrenal carcinoma, such as unexplained weight changes, new high blood pressure, or muscle weakness. Report rapid changes in body hair, periods, or blood sugar to your clinician rather than waiting.
Transmission
Adrenal carcinoma is not contagious and cannot be transferred from one person to another through touch, air, food, sex, or shared items. It does not spread through pregnancy or breastfeeding, and it is not transmitted by blood donation or transfusion. A small number of people develop adrenal carcinoma as part of an inherited cancer‑risk syndrome, where a gene change can be passed from parent to child. In these families, the genetic transmission of adrenal carcinoma refers to the inherited risk, not the cancer itself; most cases still occur sporadically without a family link. If adrenal carcinoma runs in your family, a genetics professional can explain how adrenal carcinoma is inherited and discuss screening for at‑risk relatives.
When to test your genes
Consider genetic testing if you were diagnosed with adrenal carcinoma at a young age, have tumors in both adrenal glands, or have a personal or family history of related cancers. Testing is also helpful when pathology suggests a hereditary syndrome (like Li-Fraumeni) or when treatment choices could be guided by tumor genetics. Ask for referral to genetic counseling to choose the right test and plan next steps.
Diagnosis
Adrenal carcinoma can come to light when everyday life starts feeling off—new belly or back pain, rising blood pressure, or unexpected weight or hair changes from extra hormones. For some, routine check-ups reveal the first clues. The diagnosis of adrenal carcinoma usually combines imaging and hormone testing to confirm what’s causing the symptoms and to check if it has spread. Your care team will use several steps to get a clear picture before planning treatment.
Your doctor reviews symptoms like pain, fatigue, and changes tied to hormone excess, then checks blood pressure and examines the abdomen. A detailed family and health history can help point to inherited risks or other causes.
Routine tests check electrolytes, kidney and liver function, and blood counts. Low potassium or other imbalances can hint at hormone-producing adrenal tumors.
Blood and urine tests look for excess cortisol, androgens/estrogens, or aldosterone that adrenal carcinoma can produce. Testing metanephrines helps rule out a pheochromocytoma before any biopsy or surgery.
Detailed scans show the size, shape, and texture of the adrenal mass. Features like a larger mass, irregular edges, or invasion into nearby structures can raise concern for adrenal carcinoma.
Stages of Adrenal carcinoma
Staging shows how far the tumor has grown and whether it has spread, which guides treatment and outlook. Early symptoms of adrenal carcinoma can be subtle or caused by hormone changes, so many people are diagnosed after imaging and lab tests. Early and accurate diagnosis helps you plan ahead with confidence.
Stage I
The tumor is small (up to about 5 cm, or 2 in) and limited to the adrenal gland. Adrenal carcinoma has not reached nearby lymph nodes or organs.
Stage II
The tumor is larger than 5 cm (about 2 in) but still confined to the adrenal gland. No spread to lymph nodes or distant areas is found.
Stage III
The cancer has grown into nearby tissues or involves regional lymph nodes. It may press on or attach to nearby veins or organs, but distant spread is not seen.
Stage IV
The cancer has spread to distant organs like the liver, lungs, bones, or distant lymph nodes. Adrenal carcinoma at this stage is managed to control symptoms, slow growth, and support quality of life.
Outlook and prognosis
Looking at the long-term picture can be helpful. For many people with adrenal carcinoma, the outlook depends most on how early it’s found and whether surgery can fully remove the tumor. When the cancer is caught at an early stage and the entire adrenal gland tumor is removed with clear margins, long-term control is possible, and some people do very well for years. If the cancer has spread to nearby tissues or distant organs, treatment shifts toward control—using surgery when feasible, plus medicines like mitotane, radiation, or newer systemic therapies—to manage symptoms and slow growth.
Prognosis refers to how a condition tends to change or stabilize over time. Five-year survival rates vary widely: outcomes are generally better in localized adrenal carcinoma, and lower when the disease is advanced at diagnosis. Hormone-producing tumors can add strain on blood pressure, blood sugar, or potassium levels, but controlling excess hormones often improves day-to-day energy and comfort. Recurrence is common, especially within the first two to three years, so regular imaging and lab checks are essential; catching early symptoms of adrenal carcinoma returning—such as new fatigue, high blood pressure that’s suddenly harder to manage, or unexpected weight changes—can prompt faster action.
The outlook is not the same for everyone, but with a coordinated team and close follow-up, many people maintain meaningful routines at work and home. Age, tumor size, stage, how completely the tumor was removed, and how the tumor responds to treatment all shape the path ahead. Talk with your doctor about what your personal outlook might look like, including the plan for surveillance and when to escalate treatment if scans or labs change.
Long-term effects
Adrenal carcinoma can shape health over years, both from the cancer itself and from hormones the tumor may produce. Long-term effects vary widely, depending on tumor stage at diagnosis, whether it makes excess hormones, and how well it responds to treatment. Because early symptoms of adrenal carcinoma can be subtle, some people are diagnosed later, which can affect the long-term picture. Even after treatment, some effects from past hormone imbalances or surgery may persist and need monitoring.
The cancer can come back in the adrenal area or nearby lymph nodes months to years after treatment. Risk is higher with larger or more advanced tumors at diagnosis.
Cancer cells may travel to the lungs, liver, bone, or less often the brain. This can lead to ongoing pain, breathing changes, or fractures, depending on where it settles.
Tumors that make cortisol can leave lasting effects like high blood pressure, high blood sugar, and weight gain. These changes may improve slowly after treatment but sometimes persist.
Past cortisol excess can thin bones, raising the risk of osteoporosis and fractures. Bone strength may take time to recover and may not fully return to baseline.
How is it to live with Adrenal carcinoma?
Living with adrenal carcinoma often means juggling fatigue, unintentional weight change, and swings in blood pressure or blood sugar while keeping up with frequent appointments, scans, and lab checks. Treatments like surgery, mitotane, chemotherapy, or radiation can affect energy, mood, and fertility, so planning work, meals, and rest around side effects becomes part of daily life. For many, family and friends take on practical roles—from driving to appointments to helping track medications—and they may also feel worry or strain, so clear communication and shared routines can ease the load. People often find strength in specialized care teams, counseling, and peer support, which help turn a demanding schedule into something more predictable and manageable.
Treatment and drugs
Treatment for adrenal carcinoma usually involves surgery to remove the tumor when possible, because taking out all visible cancer offers the best chance for control. If the cancer can’t be fully removed or has spread, doctors often use medicines like mitotane, chemotherapy, or targeted drugs, and may add radiation to shrink or slow tumors and ease symptoms such as pain or hormone-related issues. Treatment plans often combine several approaches, and care is typically coordinated by a team that may include endocrine surgeons, medical oncologists, and radiation specialists. Because adrenal carcinoma can make excess hormones, many people also need medicines to balance cortisol, blood pressure, potassium, or other hormone effects during and after cancer treatment. Ask your doctor about the best starting point for you, including whether clinical trials or specialized centers could offer additional options.
Non-drug treatment
Non-drug care for adrenal carcinoma focuses on removing the tumor when possible, easing symptoms, and supporting day-to-day life during and after treatment. Alongside medicines, non-drug therapies can help you stay active, manage stress, and recover from surgery or radiation. Many people first notice vague changes—fatigue or weight shifts—but early symptoms of adrenal carcinoma can be hard to pin down, so regular follow-up and self-care play a big role. Plans are tailored to tumor size, hormone effects, and your goals.
Surgeons remove the adrenal tumor, sometimes with nearby tissue to lower the chance of return. Larger adrenal carcinoma tumors often need an open operation, while smaller ones may be removed with keyhole techniques.
Nearby lymph nodes may be sampled or removed during surgery to check if cancer has spread. This helps guide follow-up care for adrenal carcinoma.
Targeted beams can treat areas that are not safely removed or reduce the risk of local return after surgery. It may also ease pain from spots that have spread.
Highly focused radiation treats small targets in a few sessions. This approach can help control limited adrenal carcinoma deposits with less impact on nearby tissue.
Your genes may have an impact on how drugs work for you
Two people can take the same adrenal carcinoma drug and respond very differently because gene differences affect how the body absorbs, activates, and clears it. Pharmacogenetic testing can sometimes guide dose or drug choice, aiming for better effect with fewer side effects.
Pharmacological treatments
Day-to-day, medicines for adrenal carcinoma aim to slow the cancer, control excess hormones, and ease symptoms like high blood pressure or weight gain from cortisol. Some work on the tumor itself, while others calm hormone surges that make people feel unwell. You might picture medicine as one tool among many—alongside surgery, radiation, and close monitoring. If new fatigue, muscle weakness, or easy bruising prompt you to ask about early symptoms of adrenal carcinoma, drug treatment may be part of the plan your team discusses.
Mitotane targets adrenal cells and can shrink or slow adrenal carcinoma. It often lowers cortisol, so steroid replacement and close blood tests are usually needed.
Etoposide, doxorubicin, and cisplatin are combined with mitotane for advanced adrenal carcinoma. This regimen can help control fast-growing disease but may cause nausea, fatigue, hair loss, and low blood counts.
When EDP is not suitable or stops working, options like gemcitabine with capecitabine or streptozocin may be tried. Benefits are modest for adrenal carcinoma, and side effects often include tiredness and low blood counts.
Pembrolizumab or nivolumab, sometimes with ipilimumab, can help a subset of people with adrenal carcinoma, especially when tumors have certain markers like mismatch-repair deficiency. Immune-related side effects can affect the skin, gut, liver, lungs, or hormones and need prompt care.
Genetic influences
For most people, adrenal carcinoma isn’t inherited; it develops because of gene changes that arise only in the tumor. A smaller share—more often in children—happens as part of an inherited risk tied to conditions such as Li-Fraumeni syndrome or Beckwith-Wiedemann syndrome. Family history is one of the strongest clues to a genetic influence. Rarely, other hereditary syndromes like Lynch syndrome or MEN1 may be involved, though adrenal cancer in these settings is uncommon. If a doctor suspects an inherited cause, genetic counseling and testing can clarify whether you or relatives carry a higher inherited risk of adrenal carcinoma and help tailor follow-up plans. Not everyone with a gene change will develop adrenal carcinoma, and the age it appears can vary even within the same family.
Is Adrenal carcinoma genetic?
Genetics plays a meaningful role in adrenal carcinoma, though most cases are sporadic. Inherited syndromes—such as Li-Fraumeni, Lynch, MEN1, and Beckwith‑Wiedemann—raise risk. Tumor genetics also guides prognosis and targeted therapies, so genetic counseling and testing are often recommended.
Pharmacogenetics—how genetics influence drug effects
People treated for adrenal carcinoma can respond very differently to the same drug, especially mitotane, which is the backbone medicine for many. Genes can influence how quickly you process mitotane and how long the drug stays in your system, which can affect both benefit and side effects. Research suggests that variants in certain liver enzyme genes (for example, CYP2B6) may change the dose needed to reach the target blood level, but pharmacogenetic testing for adrenal carcinoma isn’t routine yet, so doctors still check mitotane levels regularly and adjust.
The tumor’s own DNA can also guide therapy: if an adrenal carcinoma shows mismatch repair deficiency (trouble fixing DNA errors) or a high mutation burden (many DNA changes), immunotherapy may be an option under tumor-agnostic approvals. Inherited changes such as TP53 variants linked with Li‑Fraumeni syndrome don’t point to a specific drug, but they often influence the overall plan, including efforts to limit radiation exposure and arrange tailored screening for you and your family. In practice, your team combines tumor genetics, drug‑level monitoring, hormone needs, and your overall health to tailor care, and in some situations discussing pharmacogenetic testing for adrenal carcinoma treatment with your care team may be helpful.
Interactions with other conditions
Adrenal carcinoma can affect other health conditions because many tumors make extra hormones that push blood pressure up, raise blood sugar, thin bones, and increase clot risk. Doctors call it a “comorbidity” when two conditions occur together. Excess cortisol or aldosterone from adrenal carcinoma can worsen diabetes, high blood pressure, and heart disease, and early symptoms of adrenal carcinoma can be mistaken for more common problems like menopause changes or polycystic ovary syndrome. Some people have inherited cancer syndromes—such as Li-Fraumeni or Beckwith–Wiedemann—that raise the chance of adrenal carcinoma and may bring risks for other cancers at the same time. Treatments for adrenal carcinoma, including hormone-blocking drugs and mitotane, can interact with medicines for thyroid disease, seizures, blood pressure, or blood thinners, so doses often need careful adjustment. After surgery or when the gland is suppressed by treatment, steroid replacement may be needed; during illnesses like flu or stomach bugs, stress-dose steroids and close monitoring help prevent adrenal crises.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described sudden changes in body shape, skin, and strength that we now recognize as signs of adrenal carcinoma. A merchant in middle age who developed rapid weight gain around the trunk, darkening stretch marks, and new-onset diabetes; a young woman whose blood pressure spiked and muscles weakened so much that climbing stairs felt like a workout—stories like these appeared in medical notes long before the adrenal glands themselves were well understood.
First described in the medical literature as rare tumors found near the kidneys, adrenal growths were initially noticed at surgery or on autopsy. Early doctors could see a mass but struggled to link it to symptoms such as severe fatigue, fragile skin, or excess facial and body hair. Over time, patterns emerged: some tumors flooded the body with cortisol or other hormones, while others produced little to no hormone at all. With each decade, improved microscopes and staining techniques helped pathologists tell the difference between benign adrenal adenomas and adrenal carcinoma, which tends to invade nearby tissues and spread.
In recent decades, knowledge has built on a long tradition of observation. Imaging changed the story—first ultrasound, then CT and MRI—allowing doctors to find adrenal tumors earlier and to monitor growth and spread with much greater accuracy. Blood and urine hormone testing clarified why some people with adrenal carcinoma had features of Cushing’s syndrome or virilization, while others had vague symptoms like back pain or unexplained weight loss. Surgical advances, especially better open techniques for large or invasive tumors, became central to care, with medication such as mitotane added to help control disease in selected cases.
Advances in genetics have also reshaped understanding. Researchers identified inherited conditions—like Li-Fraumeni syndrome and multiple endocrine neoplasia—that raise the lifetime risk of developing adrenal tumors, especially in children and young adults. These findings explained why some families saw similar patterns across generations and guided careful screening for those at higher risk. Molecular studies uncovered changes in tumor cells that drive growth, shedding light on why adrenal carcinoma behaves aggressively and why early symptoms of adrenal carcinoma can be so varied.
Despite evolving definitions, the core goal has stayed steady: find adrenal carcinoma earlier and treat it more effectively. International registries and collaborative studies have been essential for such a rare cancer, helping refine staging systems and treatment plans used around the world. Today’s approach—combining careful imaging, hormone evaluation, expert surgery, and, when needed, targeted medications—stands on more than a century of observations, missteps, and breakthroughs that brought the condition into clearer focus.